Chronic Obstructive Pulmonary Disease
📧 Sign up to get email alerts when something new happens for Chronic Obstructive Pulmonary Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-03-23Clinical Trial Update: Rehabilitation in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD) [NA]
This document provides an update on a completed clinical trial evaluating rehabilitation in adults with moderate Chronic Obstructive Pulmona…
-
CLINICAL_TRIALS other · 2011-03-21Clinical Trial Update: Impact of a Hospital Physical Therapy Program on Chronic Obstructive Pulmonary Disease (COPD) Patients [NA]
A clinical trial update examines the impact of a hospital-based physical therapy program on patients with Chronic Obstructive Pulmonary Dise…
-
CLINICAL_TRIALS trial_result · 2011-03-08Clinical Trial Update: Real-life Effectiveness and Cost-effectiveness of Qvar Versus FP and BDP in the Management of COPD
A completed real-world study comparing the effectiveness and cost-effectiveness of Qvar (beclomethasone dipropionate) versus fluticasone pro…
-
CLINICAL_TRIALS trial_result · 2011-03-04Clinical Trial Update: Prophylactic Efficacy of Relenza Against Influenza A and B
Completed clinical trial results evaluating whether Relenza (zanamivir) can prevent influenza A and B infections.
-
CLINICAL_TRIALS trial_result · 2011-03-02Clinical Trial Update: Effects of Tiotropium on Walking Capacity in Patients With COPD [Phase 4]
Phase 4 clinical trial assessing tiotropium's effect on walking capacity in chronic obstructive pulmonary disease has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2011-02-28FDA Approved: DALIRESP — Original Application (AstraZeneca Pharmaceuticals LP)
FDA approved the original application for Daliresp (roflumilast), a PDE-4 inhibitor, to reduce the risk of COPD exacerbations in patients wi…
-
CLINICAL_TRIALS trial_result · 2011-02-28Clinical Trial Update: Predicting Oxygen Desaturation in Chronic Obstructive Pulmonary Disease (COPD) Patients
Clinical trial evaluating prediction of oxygen desaturation in chronic obstructive pulmonary disease patients has completed.
-
CLINICAL_TRIALS trial_result · 2011-02-24Clinical Trial Update: Noninvasive Ventilatory Support After Lung Surgery in COPD Patients [NA]
Clinical trial update indicating a completed study on noninvasive ventilatory support after lung surgery in patients with chronic obstructiv…
-
CLINICAL_TRIALS trial_result · 2011-02-24Clinical Trial Update: Action Plan to Enhance Self-management and Early Detection of Exacerbations in Chronic Obstructive Pulmonary Disease (COPD) Patients [NA]
This update reports the completion of a clinical trial led by UMC Utrecht. The study evaluated an action plan to enhance self-management and…
-
CLINICAL_TRIALS trial_result · 2011-02-23Clinical Trial Update: A Project Ensuring Quality and Cooperation in the Chronic Obstructive Pulmonary Disease (COPD) Treatment
This is a completed clinical trial update for a COPD treatment project sponsored by AstraZeneca, indicating the study has finished.
-
CLINICAL_TRIALS research · 2011-02-21Clinical Trial Update: Effects of Transcutaneous Electrical Diaphragmatic Stimulation on Respiratory Variables in COPD Patients [Phase 1, Phase 2]
This clinical trial update reports on the investigation of transcutaneous electrical diaphragmatic stimulation as a potential therapy for ch…
-
FDA approval · 2011-02-16FDA Approved: BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for budesonide and formoterol fumarate dihydrate (Symbicort) from AstraZeneca Pharmaceuticals LP.
-
CLINICAL_TRIALS trial_result · 2011-02-16Clinical Trial Update: To Evaluate the Effect of AZD3199 on the Electrical Activity in the Heart [Phase 1]
A Phase 1 trial sponsored by AstraZeneca evaluated the effect of AZD3199 on cardiac electrical activity in people with chronic obstructive p…
-
CLINICAL_TRIALS trial_result · 2011-02-16Clinical Trial Update: Oxygen Portable Concentrator During Exercises in Patients With COPD [NA]
A completed clinical trial evaluated the use of a portable oxygen concentrator during exercise in patients with Chronic Obstructive Pulmonar…
-
CLINICAL_TRIALS research · 2011-02-15Clinical Trial Update: Effectiveness of Regular Reporting of Spirometric Results on Smoking Quit Rate. [NA]
This clinical trial update assesses whether regular reporting of spirometric results improves smoking quit rates among individuals with nico…
-
CLINICAL_TRIALS trial_result · 2011-02-10Clinical Trial Update: Effectiveness and Safety of BIO-11006 Inhalation Solution to Treat the Overproduction of Mucus and Inflammation in COPD [Phase 2]
Phase 2 clinical trial evaluating BIO-11006 inhalation solution for reducing mucus overproduction and inflammation in chronic obstructive pu…
-
CLINICAL_TRIALS trial_result · 2011-02-09Clinical Trial Update: Sensitivity of New Exercise Tests in Chronic Obstructive Pulmonary Disease (COPD) [NA]
A completed clinical trial evaluating the sensitivity of new exercise tests in chronic obstructive pulmonary disease.
-
CLINICAL_TRIALS trial_result · 2011-02-08Clinical Trial Update: Optimization of Ventilator Setting for Acute Exacerbations of Chronic Obstructive Pulmonary Disease [NA]
A completed clinical trial from the University of Milan evaluating ventilator setting optimization for acute exacerbations of chronic obstru…
-
FDA approval · 2011-02-01FDA Approved: FORMOTEROL FUMARATE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for Formoterol Fumarate submitted by Mylan Pharmaceuticals, resulting in a change to the product…
-
CLINICAL_TRIALS trial_result · 2011-02-01Clinical Trial Update: Efficacy of DNK333 in Patients With COPD and Cough [Phase 1, Phase 2]
Phase 1/2 trial of DNK333 in chronic obstructive pulmonary disease with cough has completed and shown efficacy signals.
-
CLINICAL_TRIALS trial_result · 2011-01-28Clinical Trial Update: Symbicort in Chronic Obstructive Pulmonary Disease
The document reports the completion of a clinical trial evaluating Symbicort for Chronic Obstructive Pulmonary Disease.
-
CLINICAL_TRIALS trial_result · 2011-01-28Clinical Trial Update: Study to Investigate Daily Symptom Variability, Symptom Effects on Morning Activities of Chronic Obstructive Disease
AstraZeneca-sponsored clinical trial completed evaluating daily COPD symptom variability and the impact of symptoms on morning activities. T…
-
CLINICAL_TRIALS trial_result · 2011-01-28Clinical Trial Update: SYMBICORT® in the Treatment of COPD
This document reports the completion of a clinical trial evaluating SYMBICORT for the treatment of chronic obstructive pulmonary disease.
-
CLINICAL_TRIALS trial_result · 2011-01-24Clinical Trial Update: Comparison Between Symbicort® and Prednisolone in COPD [Phase 3]
Phase 3 trial comparing Symbicort with prednisolone in chronic obstructive pulmonary disease has completed, providing head-to-head results i…
-
CLINICAL_TRIALS trial_result · 2011-01-24Clinical Trial Update: Budesonide / Formoterol in Treatment of Exacerbations of COPD [Phase 2]
A Phase 2 trial evaluating budesonide/formoterol for treatment of COPD exacerbations has completed.